Emilia Zwolińska, Lidia Główka, Adam Chicheł, Iwona Rospond-Kubiak
{"title":"Ruthenium brachytherapy for iris melanoma","authors":"Emilia Zwolińska, Lidia Główka, Adam Chicheł, Iwona Rospond-Kubiak","doi":"10.5114/jcb.2023.132401","DOIUrl":null,"url":null,"abstract":"AMA Zwolińska E, Główka L, Chicheł A, Rospond-Kubiak I. Ruthenium brachytherapy for iris melanoma. Journal of Contemporary Brachytherapy. 2023. doi:10.5114/jcb.2023.132401. APA Zwolińska, E., Główka, L., Chicheł, A., & Rospond-Kubiak, I. (2023). Ruthenium brachytherapy for iris melanoma. Journal of Contemporary Brachytherapy. https://doi.org/10.5114/jcb.2023.132401 Chicago Zwolińska, Emilia, Lidia Główka, Adam Chicheł, and Iwona Rospond-Kubiak. 2023. \"Ruthenium brachytherapy for iris melanoma\". Journal of Contemporary Brachytherapy. doi:10.5114/jcb.2023.132401. Harvard Zwolińska, E., Główka, L., Chicheł, A., and Rospond-Kubiak, I. (2023). Ruthenium brachytherapy for iris melanoma. Journal of Contemporary Brachytherapy. https://doi.org/10.5114/jcb.2023.132401 MLA Zwolińska, Emilia et al. \"Ruthenium brachytherapy for iris melanoma.\" Journal of Contemporary Brachytherapy, 2023. doi:10.5114/jcb.2023.132401. Vancouver Zwolińska E, Główka L, Chicheł A, Rospond-Kubiak I. Ruthenium brachytherapy for iris melanoma. Journal of Contemporary Brachytherapy. 2023. doi:10.5114/jcb.2023.132401.","PeriodicalId":51305,"journal":{"name":"Journal of Contemporary Brachytherapy","volume":"122 1","pages":"0"},"PeriodicalIF":1.1000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Contemporary Brachytherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/jcb.2023.132401","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
AMA Zwolińska E, Główka L, Chicheł A, Rospond-Kubiak I. Ruthenium brachytherapy for iris melanoma. Journal of Contemporary Brachytherapy. 2023. doi:10.5114/jcb.2023.132401. APA Zwolińska, E., Główka, L., Chicheł, A., & Rospond-Kubiak, I. (2023). Ruthenium brachytherapy for iris melanoma. Journal of Contemporary Brachytherapy. https://doi.org/10.5114/jcb.2023.132401 Chicago Zwolińska, Emilia, Lidia Główka, Adam Chicheł, and Iwona Rospond-Kubiak. 2023. "Ruthenium brachytherapy for iris melanoma". Journal of Contemporary Brachytherapy. doi:10.5114/jcb.2023.132401. Harvard Zwolińska, E., Główka, L., Chicheł, A., and Rospond-Kubiak, I. (2023). Ruthenium brachytherapy for iris melanoma. Journal of Contemporary Brachytherapy. https://doi.org/10.5114/jcb.2023.132401 MLA Zwolińska, Emilia et al. "Ruthenium brachytherapy for iris melanoma." Journal of Contemporary Brachytherapy, 2023. doi:10.5114/jcb.2023.132401. Vancouver Zwolińska E, Główka L, Chicheł A, Rospond-Kubiak I. Ruthenium brachytherapy for iris melanoma. Journal of Contemporary Brachytherapy. 2023. doi:10.5114/jcb.2023.132401.
AMA Zwolińska E, Główka L, Chicheł A, Rospond-Kubiak I. Ruthenium brachytherapy for iris melanoma.当代近距离治疗杂志》。2023. doi:10.5114/jcb.2023.132401.APA Zwolińska, E., Główka, L., Chicheł, A., & Rospond-Kubiak, I. (2023)。用于虹膜黑色素瘤的钌近距离放射治疗。https://doi.org/10.5114/jcb.2023.132401 Chicago Zwolińska, Emilia, Lidia Główka, Adam Chicheł, and Iwona Rospond-Kubiak.2023."治疗虹膜黑色素瘤的钌近距离放射疗法》。doi:10.5114/jcb.2023.132401。Harvard Zwolińska, E., Główka, L., Chicheł, A., and Rospond-Kubiak, I. (2023).治疗虹膜黑色素瘤的钌近距离放射疗法。https://doi.org/10.5114/jcb.2023.132401 MLA Zwolińska, Emilia et al. "虹膜黑色素瘤的钌近距离治疗"。Doi:10.5114/jcb.2023.132401.Vancouver Zwolińska E, Główka L, Chicheł A, Rospond-Kubiak I. Ruthenium brachytherapy for iris melanoma.当代近距离治疗杂志》。2023. doi:10.5114/jcb.2023.132401.
期刊介绍:
The “Journal of Contemporary Brachytherapy” is an international and multidisciplinary journal that will publish papers of original research as well as reviews of articles. Main subjects of the journal include: clinical brachytherapy, combined modality treatment, advances in radiobiology, hyperthermia and tumour biology, as well as physical aspects relevant to brachytherapy, particularly in the field of imaging, dosimetry and radiation therapy planning. Original contributions will include experimental studies of combined modality treatment, tumor sensitization and normal tissue protection, molecular radiation biology, and clinical investigations of cancer treatment in brachytherapy. Another field of interest will be the educational part of the journal.